|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
21.900 +0.140 (+0.643%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.33
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | -84.00 RMB (cts) | |
| Net Profit | -840.91 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | -604.00 | -59.00 | 0 | -- | -354.00 | -630.00 |
| 2027 | -291.00 | -28.00 | 0 | -- | 68.00 | -454.00 |
| 2028 | 167.50 | 16.50 | 0 | -- | 582.00 | -247.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | -354.00 | -35.00 | -- | UBS | Buy | 32.90 | 19/03/2026 | |
| 2026 | -630.00 | -61.30 | -- | CITIGROUP | Buy | 32.00 | 16/03/2026 | |
| 2026 | -604.00 | -59.00 | -- | JP MORGAN | Neutral | 20.00 | 17/03/2026 | |
| 2027 | 68.00 | 7.00 | -- | UBS | -- | -- | 19/03/2026 | |
| 2027 | -454.00 | -44.20 | -- | CITIGROUP | -- | -- | 16/03/2026 | |
| 2027 | -291.00 | -28.00 | -- | JP MORGAN | -- | -- | 17/03/2026 | |
| 2028 | 582.00 | 57.00 | -- | UBS | -- | -- | 19/03/2026 | |
| 2028 | -247.00 | -24.00 | -- | CITIGROUP | -- | -- | 16/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 20/03/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -840,910 |
| %Change | -34.427% |
| EPS / (LPS) | RMB -0.840 |
| NBV Per Share (¥) | RMB 5.895 |